医薬品製造受託の世界市場

【英語タイトル】Pharmaceutical Contract Manufacturing Market 2018-2028

visiongainが出版した調査資料(VGN808045)・商品コード:VGN808045
・発行会社(調査会社):visiongain
・発行日:2018年6月
・ページ数:230
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:医薬品
◆販売価格オプション(消費税別)
Sigle User(1名様閲覧用)GBP2,699 ⇒換算¥410,248見積依頼/購入/質問フォーム
Five User(5名様閲覧用)GBP2,999 ⇒換算¥455,848見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)GBP4,999 ⇒換算¥759,848見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
visiongain社が発行した当調査レポートでは、医薬品製造受託の世界市場について調査・分析し、医薬品製造受託の世界市場規模、市場動向、市場予測、関連企業情報などを含め、以下の構成でお届けいたします。
【レポートの概要】

The pharmaceutical contract manufacturing market is expected to grow at a CAGR of 6.0% in the first half of the forecast period. The API Manufacturing submarket held 66% of the market in 2017. Visiongain estimated that the pharmaceutical contract manufacturing market will reach $93bn in 2022.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 230-page report you will receive 77 tables and 58 figures– all unavailable elsewhere.

The 230-page report provides clear detailed insight into the pharmaceutical contract manufacturing market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Pharmaceutical Contract Manufacturing Market forecasts from 2018-2028

• Submarket forecasts at world level, from 2018-2028:
• Active pharmaceutical ingredients (APIs), with sub forecasts for generic APIs, high potency active pharma ingredients (HPAPIs) and other products
• Finished dosage formulations (FDFs), with sub forecasts for solid dose forms, injectable dosages and other dosage types
• Other applications of outsourced production – other related services

• Revenue forecasts from 2018-2028, for these regional and national markets:
• The US
• Canada
• Japan
• EU5: Germany, France, the UK, Italy and Spain
• BRIC: Brazil, Russia, India, China
• South Korea
• Turkey
• Mexico
• Others

Pharmaceutical Contract Manufacturing Market 2018-2028

• Assessment of selected leading companies that hold major market shares in the pharmaceutical contract manufacturing industry

• Qualitative Analysis from a CMO Perspective

• Qualitative Analysis from a Client Perspective

Visiongain’s study is intended for anyone requiring commercial analyses for the pharmaceutical contract manufacturing market. You find data, trends and predictions.

Buy our report today Pharmaceutical Contract Manufacturing Market 2018-2028: Active Ingredient (API) and Finished Dose Formulation (FDF), Generic APIs, HPAPIs, Solid Dosages, Injectable Dosages.

【レポートの目次】

1. Report Overview

1.1 Global Pharmaceutical Contract Manufacturing Market Segmentation

1.2 Global Pharmaceutical Contract Manufacturing Market Overview

1.3 Why You Should Read This Report

1.4 How This Report Delivers

1.5 Key Questions Answered by This Analytical Report

1.6 Who is This Report For?

1.7 Methodology

1.8 Frequently Asked Questions (FAQ)

1.9 Associated Visiongain Reports

1.10 About Visiongain

2. Introduction to Pharmaceutical Contract Manufacturing

2.1 What is Pharmaceutical Contract Manufacturing?

2.2 The Benefits of Outsourcing in the Pharmaceutical Market

2.3 Pharmaceutical Contract Manufacturing Services

2.4 Strategy and Tactics: The Importance of Outsourcing Wisely

2.5 Trends in Contract Manufacturing, 2017-2028

2.6 Pharmaceutical Contract Manufacturing: Market Segmentation

3. Pharmaceutical Contract Manufacturing: World Market 2017-2028

3.1 Pharmaceutical Contract Manufacturing Market: Historical Performance 2013-2017

3.1.1 Contract Manufacturing is the Most Mature Pharma Outsourcing Sector

3.1.2 The Pharma Contract Manufacturing Market by Sector 2017

3.2 Pharma Contract Manufacturing: Overall Market Forecast 2017-2028

3.2.1 Changing Market Shares by Segment 2017-2028

3.2.2 Drivers for Growth in the Contract Manufacturing Market to 2028

3.2.3 Generics: A Driver or Restraint?

3.2.4 Other Contract Manufacturing Services Market: Outlook and Forecast, 2017-2028

3.2.4.1 Increasing Demand for Formulation Development Services

4. The Contract API Manufacturing Services Submarket 2017-2028

4.1 The Contract API Manufacturing Submarket 2015-2017

4.1.1 Chemical APIs Will Experience Resurgence after the Shift of Focus to Biological APIs

4.1.2 The API Manufacturing Submarket by Sector, 2016

4.2 The Contract API Manufacturing Submarket: Outlook and Forecast 2017-2028

4.2.1 Drivers for Growth in the API Submarket to 2028

4.2.2 The Potential for Microreactors in Commercial Manufacturing to 2028

4.2.3 How Will New EU Regulations Impact the API Manufacturing Submarket?

4.2.4 Contract API Manufacturing Submarket Restraint 2017-2028

4.2.4.1 Backwards Integration for Generics Manufacturers

4.3 The Contract Generic API Manufacturing Submarket 2017-2028

4.3.1 The Contract Generic API Manufacturing Submarket Forecast 2017-2028

4.3.2 The Contract Generic API Manufacturing Submarket Drivers and Restraints to 2028

4.3.2.1 The US Generic Drug User Fee Act and API Manufacturing

4.4 The Contract HPAPI Manufacturing Submarket 2017-2028

4.4.1 Challenges and Opportunities in High Containment Manufacturing

4.4.2 Company Investment into HPAPI Manufacturing Facilities: Growth Increases in the HPAPI Manufacturing Sector

4.4.3 The Contract HPAPI Manufacturing Submarket Forecast 2017-2028

4.4.4 The Contract HPAPI Manufacturing Submarket Drivers and Restraints to 2028

5. The Contract FDF Manufacturing Services Submarket 2017-2028

5.1 The Contract FDF Manufacturing Submarket, 2017

5.1.1 Solid Dosage Manufacturing Leads the Market

5.1.2 CMOs Report High Demand for Softgel Formulations

5.2 The Contract FDF Manufacturing Submarket Forecast 2017-2028

5.2.1 Complex Molecule Manufacturing Will Drive Growth to 2028

5.2.2 What Will Restrain Growth in FDF Outsourcing?

5.3 The Contract Solid Dosage Manufacturing Submarket 2017-2028

5.3.1 How Will Revenue for Solid Dosage Manufacturing Grow to 2028?

5.3.2 The Solid Dosage Manufacturing Submarket Drivers and Restraints 2017-2028

5.3.2.1 Will Product Reformulation Drive Growth to 2028?

5.4 The Contract Injectable Dosage Manufacturing Submarket 2017-2028

5.4.1 The Contract Injectable Dosage Manufacturing Submarket Forecast 2017-2028

5.4.1.1 Drug Shortages Offer Opportunity to CMOs in the Short-Term

5.4.2 Demand for Biopharma Manufacturing Will Drive Growth 2017-2028

5.4.2.1 Interest in Antibody-Drug Conjugate Development Is Growing

5.4.2.2 Challenges in Manufacturing Antibody-Drug Conjugates

5.4.3 Lyophilisation and Aseptic Filling Demand Will Rise

5.4.3.1 Will Spray Drying Replace Lyophilisation in FDF Manufacturing?

6. Leading National Markets for Pharmaceutical Contract Manufacturing 2017-2028

6.1 Leading National Markets for Pharmaceutical Contract Manufacturing, 2017

6.1.1 Challenges in Assessing the Market: Supply versus Demand

6.1.2 Leading National Pharmaceutical Contract Manufacturing Markets: Revenue Forecasts 2017-2028

6.1.3 Pharmaceutical Manufacturing in the US: Regulatory Oversight, 2017

6.1.4 Controlling Foreign Manufacturing Sites

6.1.5 What Impact Will the GDUFA 2012 Have on Foreign Manufacturing?

6.1.6 Outsourcing and US Manufacturing Regulations

6.1.7 Increased Demand for Domestic API Manufacturing?

6.2 The US Contract Manufacturing Market Forecast 2017-2028

6.3 The Canada Contract Manufacturing Market Forecast 2017-2028

6.4 Outlook for Pharmaceutical Contract Manufacturing in the EU

6.4.1 The EU is the Leading Destination for Pharmaceutical Contract Manufacturing

6.4.2 Regulatory Aspects of Pharma Manufacturing in the EU

6.4.2.1 The European Commission Amends Annex 16

6.4.2.2 The Falsified Medicine Directive: Controlling API Imports

6.4.3 Biopharma Manufacturing Demand Will Rise to 2028

6.4.4 The EU Contract Manufacturing Market Forecast 2017-2028

6.4.5 Germany: The Leading EU Destination for API and FDF Manufacturing

6.4.5.1 Demand for Contract Manufacturing in Germany: Revenue Forecast 2017-2028

6.4.6 CMOs Account for a Third of Manufacturing Sites in France

6.4.6.1 French Pharma Contract Manufacturing Market Forecast 2017-2028

6.4.7 Italy: Strong API Manufacturing Traditions

6.4.7.1 Revenue Forecast for the Italian Pharma Contract Manufacturing Market 2017-2028

6.4.8 Spain: How Will Demand for Manufacturing Services Grow to 2028?

6.4.9 UK: Pharmaceutical Contract Manufacturing Market Forecast 2017-2028

6.5 Pharma Contract Manufacturing in Japan to 2028

6.5.1 Pharmaceutical Manufacturing Regulations in Japan

6.5.1.1 The Pharmaceutical Affairs Law

6.5.2 Greater API Outsourcing to Drive Japanese Market Growth to 2028 In Spite of Currency Devaluation Weakening the Economy

7. Leading Emerging Markets for Pharmaceutical Contract Manufacturing Market 2017-2028

7.1 Pharmaceutical Contract Manufacturing in Developing Countries

7.1.1 Outsourcing to Emerging National Markets from Developed Markets

7.1.1.1 Demand Will Increase for Services in India and China

7.1.2 Domestic Demand for Pharmaceutical Contract Manufacturing Services

7.1.3 Pharmaceutical Contract Manufacturing: Leading Emerging National Market Forecasts 2017-2028

7.2 Chinese Demand for Pharma Contract Manufacturing Services 2017-2028

7.2.1 Improved Manufacturing Regulations in China

7.2.1.1 Regulations for Excipients and Guidance for API Manufacturing

7.2.1.2 What Are the Consequences to Stricter Manufacturing Regulations in China?

7.2.2 Chinese CMOs Are Investing in Biopharma Manufacturing

7.2.3 China Pharma Contract Manufacturing Market Forecast 2017-2028

7.3 India: CMOs with Strong Infrastructure and Growing Expertise

7.3.1 Regulatory Outlook for Indian Pharma Manufacturing

7.3.1.1 Stricter Quality Standards to Ensure Compliance with EU Rules

7.3.2 Domestic Manufacturing Dominates the Indian Pharma Market

7.3.3 Demand for Contract Manufacturing in India: Market Forecast 2017-2028

7.4 Brazil: Contract Manufacturing Outlook 2017-2028

7.4.1 Pharmaceutical Manufacturing Regulations in Brazil

7.4.1.1 Guidelines and Regulations Proposed

7.4.2 Brazil Imports Most of its APIs

7.4.3 Brazil: Pharma Contract Manufacturing Market Forecast 2017-2028

7.5 The Russian Pharma Contract Manufacturing Market 2017-2028

7.5.1 Pharma Manufacturing Regulations in Russia

7.5.1.1 Compliance with GMP in Russia

7.5.2 How Will Demand for Contract Manufacturing Grow in Russia to 2028?

7.6 South Korea: Government Supported Growth

7.6.1 South Korea: Strict GMP Regulations

7.6.2 South Korea: Pharma Contract Manufacturing Market Forecast 2017-2028

7.7 Turkey: Domestic Market to offer Huge Growth Opportunities

7.7.1 Turkey: An Important Hub for Global Pharma Companies

7.7.2 Drug Approvals Delaying Growth of the Turkey Pharma Market

7.7.3 Turkey: Pharma Contract Manufacturing Market Forecast 2017-2028

7.8 Mexico: Emerging Market Power

7.8.1 Healthcare – A Top Priority in Mexico

7.8.2 Strategic Management of High Expectations

7.8.3 Mexico: Pharma Contract Manufacturing Market Forecast 2017-2028

8. Leading Companies in the Pharmaceutical Contract Manufacturing Market

8.1 Leading CMOs in the Pharmaceutical Contract Manufacturing Market

8.2 Catalent: Leading CMO

8.2.1 Multiple Expansions and Increased Focus on Biologic Manufacturing

8.2.2 Recent Developments

8.3 Lonza: Potential to Lead in ADC Manufacturing

8.3.1 Lonza: Expanding its Capacities to Meet Customer Demand for Biologic Manufacturing

8.3.2 Recent Developments

8.4 Evonik Degussa: Specialising in Small Molecules

8.4.1 Recent Developments

8.5 DPx Holdings – DSM and Patheon: Recent Merger Has Strengthened Their Position

8.5.1 Increasing Capacity Tactically and Expanding Worldwide

8.6 Teva: The World’s Largest API Manufacturer

8.6.1 Will Teva Expand into Emerging Markets?

8.6.2 Recent Developments

8.7 Boehringer Ingelheim BioXcellence: Boehringer’s Biopharma Manufacturing Division

8.7.1 Recent Developments

8.7.2 Adding New Services for Growth

8.8 Famar: A Possible Candidate for Acquisition

8.8.1 Recent Developments

8.9 Fareva: A Strategic Shift from Acquisition to Increase in Capacity

8.10 Vetter Pharma: Specialists in Aseptic Filling, Lyophilisation and Siliconisation

8.10.1 Vetter’s Growth: Increasing in Capacity and Market Expansion

8.11 Mylan: A World Leader in Generics Manufacturing

8.11.1 Recent Developments


9. Pharmaceutical Contract Manufacturing Industry Trends: Qualitative Analysis from a CMO Perspective 2017-2028

9.1 Pharma Contract Manufacturing Market: Strengths and Weaknesses from a CMO Perspective 2017-2028

9.2 Pharma Contract Manufacturing Market: Opportunities and Threats from a CMO Perspective 2017-2028

9.3 Pharma Contract Manufacturing Market: STEP Analysis 2017-2028

9.3.1 Social Factors

9.3.2 New Technologies Will Drive Market Growth to 2028

9.3.2.1 Advantages of Single-Use Technologies in Biopharma Manufacturing

9.3.2.2 Green Technology in Contract Manufacturing

9.3.2.3 Drug Delivery Trends and CMOs

9.3.2.4 Biologics Are Causing Increased Demand for Lyophilisation

9.3.2.5 Improving Solubility and Stability for Small Molecules

9.3.2.6 Spray Drying as an Advantageous Alternative to Lyophilisation

9.3.2.7 Hot-Melt Extrusion: A Niche Opportunity

9.3.3 Economic Pressures

9.3.3.1 Developed-Market CMOs Facing Competition from Emerging Markets

9.3.4 Political Issues

9.3.4.1 How Will Regulatory Developments Affect CMOs?

9.4 Trends in Drug Development Affecting CMOs to 2028

9.4.1 Orphan Drug Development: Smaller Manufacturing Capacities

9.4.2 Complex Biologics: Interest in ADCs is increasing

9.4.3 How Will Biosimilar Market Growth Affect CMOs?

9.4.4 The Future of Small Molecule Outsourcing

9.5 How Will CMOs Expand in the Coming 10 Years?

9.5.1 CMO Consolidation Will Increase

9.5.2 There Will Be More Manufacturing Facilities Available for Acquisition

9.6 Developments in the Manufacturing Process 2017-2028

9.6.1 Rising Interest from Companies in Quality by Design (QbD)

9.6.2 A Move Towards Continuous Manufacturing



10. Pharmaceutical Contract Manufacturing Trends: Qualitative Analysis of the Pharmaceutical Contract Manufacturing Market from a Client Perspective 2017-2028

10.1 Pharma Contract Manufacturing Market: Strengths and Weaknesses from a Client Perspective 2017-2028

10.2 Pharma Contract Manufacturing Market: Opportunities and Threats from a Client Perspective 2017-2028

10.3 Important Aspects of the Outsourcing Decision

10.3.1 What Factors Will Influence CMO Selection?

10.3.2 CMO - Pharma Partnering Models

10.3.3 Strategic Partnering

10.3.4 Selecting a Local CMO vs. Offshoring

10.3.5 CMOs in Emerging Markets

10.3.6 Good Communication is Vital for Success

10.3.7 Ensuring Protection in Intellectual Property and Tech Transfer

10.3.8 Regulatory Compliance is a Key Deciding Factor for Pharma Clients

10.3.8.1 Regulatory Bodies and Outsourcing

10.3.8.2 Quality Agreement

10.3.8.3 Global Harmonisation Will Improve Compliance

10.4 Trends in Outsourcing Partnerships 2017-2028

10.4.1 Big Pharma and Outsourced Manufacturing

10.4.2 Small and Virtual Pharma Companies

10.4.3 How Will Biotech Funding Impact the Pharma Contract Manufacturing Industry to 2028?


11. Conclusions

11.1 The World Pharmaceutical Contract Manufacturing Market

11.2 Outlook for the Market to 2028

11.2.1 Rising Demand for High Value Services 2017-2028

11.2.2 Demand Will Be Highest Among Developed-Market Clients

11.3 Which New Technologies Will Stimulate Demand to 2028?


Appendices

Associated Visiongain Reports

Visiongain Report Sales Order Form

About Visiongain

Visiongain report evaluation form


List of Tables

Table 3.1 Pharma Contract Manufacturing World Market Revenue ($bn), Annual Growth (%), CAGR (%), 2012-2016

Table 3.2 Pharma Contract Manufacturing Market: Revenue ($bn) and Market Share (%) by Sector, 2017

Table 3.3 Pharmaceutical Contract Manufacturing Market: Overall Market Forecasts by Sector, Revenue ($bn), Annual Growth (%), CAGR (%), 2017-2028

Table 3.4 Pharma Contract Manufacturing Market: Market Shares (%), 2017-2022

Table 3.5Pharma Contract Manufacturing Market: Market Shares (%), 2023-2028

Table 3.6 Other Services Submarket Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2017-2028

Table 4.1 Contract API Manufacturing Submarket Revenue ($bn), Annual Growth (%), CAGR (%), 2012-2016

Table 4.2 Contract API Manufacturing Submarket: Revenue ($bn) and Submarket Share (%) by Sector, 2017

Table 4.3 Contract API Manufacturing Submarket: Overall Submarket Forecasts by Sector, Revenue ($bn), Annual Growth (%), CAGR (%), 2017-2028

Table 4.4 Contract API Manufacturing Submarket Shares (%), 2017-2022

Table 4.5 Contract API Manufacturing Submarket Shares (%), 2022-2028

Table 4.6 Contract API Manufacturing Submarket: Drivers and Restraints, 2017-2028

Table 4.7 Contract Generic API Manufacturing Submarket Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2017-2028

Table 4.8 Contract Generic API Manufacturing Submarket: Drivers and Restraints, 2017-2028

Table 4.9 Contract HPAPI Manufacturing Submarket Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2017-2028

Table 4.10 Contract HPAPI Manufacturing Submarket: Drivers and Restraints, 2017-2028

Table 5.1 Contract FDF Manufacturing Submarket Revenue ($bn), Annual Growth (%), 2012-2016

Table 5.2 Contract FDF Manufacturing Submarket: Revenue ($bn) and Submarket Share (%) by Sector, 2017

Table 5.3 Contract FDF Manufacturing Submarket: Overall Submarket Forecasts by Sector, Revenue ($bn), Annual Growth (%), CAGR (%), 2017-2028

Table 5.4 Contract FDF Manufacturing Submarket: Segment Shares (%), 2017-2022

Table 5.5 Contract FDF Manufacturing Submarket: Segment Shares (%), 2022-2028

Table 5.6 Contract FDF Manufacturing Submarket: Drivers and Restraints, 2017-2028

Table 5.7 Contract Solid Dosage Manufacturing Submarket Forecast, Revenue ($bn), Annual Growth (%), CAGR (%) 2017-2028

Table 5.8 Contract Solid Dosage Manufacturing Submarket: Drivers and Restraints, 2017-2028

Table 5.9 Contract Injectable Dosage Manufacturing Submarket Forecast, Revenue ($bn), Annual Growth (%), CAGR (%) 2017-2028

Table 5.10 Contract Injectable Dosage Manufacturing Submarket: Drivers and Restraints, 2017-2028

Table 5.11 Selected ADCs in Development, 2016

Table 5.12 Selected CMOs Investing in ADC Manufacturing Capacity

Table 6.1 Pharma Contract Manufacturing Market: Revenues ($bn) and Market Shares (%) by Region, 2017

Table 6.2 Pharma Contract Manufacturing Market: Regional Forecasts, Revenue ($bn), Annual Growth (%), CAGR (%), 2017-2028

Table 6.3 Pharmaceutical Contract Manufacturing Market: Submarket Shares (%), 2017-2022

Table 6.4 Pharmaceutical Contract Manufacturing Market: Submarket Shares (%), 2022-2028

Table 6.5 GDUFA: Annual Fees for Domestic and Foreign Manufacturing Sites, 2015-2016

Table 6.6 US Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2017-2028

Table 6.7 Canada Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2017-2028

Table 6.8 EU Pharma Contract Manufacturing Market: Revenue ($bn) and Market Share (%) by Leading Country, 2017

Table 6.9 EU Pharma Contract Manufacturing Market: Revenue ($bn) and Market Share (%) by Leading Country, 2022

Table 6.10 EU Pharma Contract Manufacturing Market: Revenue ($bn) and Market Share (%) by Leading Country, 2028

Table 6.11 EU5 Pharma Contract Manufacturing Market: National Market Forecasts, Revenue ($bn), Annual Growth (%), CAGR (%), 2017-2028

Table 6.12 German Pharma Contract Manufacturing: Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2017-2028

Table 6.13 Selected French Manufacturing Site Acquisitions, 2009-2013

Table 6.14 French Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2017-2028

Table 6.15 Italian Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2017-2028

Table 6.16 Spanish Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2017-2028

Table 6.17 UK Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2017-2028

Table 6.18 Japanese Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2017-2028

Table 7.1 Pharma Contract Manufacturing Market: Emerging Market Revenue ($bn) and Market Share (%) by Top Country, 2017

Table 7.2 Pharma Contract Manufacturing Market: Leading Emerging Market Forecasts ($bn), Annual Growth (%), CAGR (%), 2017-2028

Table 7.3 Pharma Contract Manufacturing Market: Emerging Market Shares (%), 2017-2022

Table 7.4 Pharma Contract Manufacturing Market: Emerging Market Shares (%), 2022-2028

Table 7.5 Chinese Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2017-2028

Table 7.6 Indian Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2017-2028

Table 7.7 Brazilian Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2017-2028

Table 7.8 Russian Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2017-2028

Table 7.9 South Korean Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2017-2028

Table 7.10 Turkey Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2017-2028

Table 7.11 Mexico Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2017-2028

Table 8.1 Catalent: Revenue ($bn), Annual Growth, CAGR, 2012-2017

Table 8.2 Lonza: Revenue (CHF bn), Annual Growth (%), CAGR (%), 2012-2017

Table 8.3 Teva: Revenue ($bn), Annual Growth (%), CAGR (%), 2012-2017

Table 8.4 Boehringer Ingelheim BioXcellence: Revenue (CHF bn), Annual Growth (%), CAGR (%), 2012-2017

Table 9.1 Pharma Contract Manufacturing Market Strengths and Weaknesses: CMO Perspective, 2017-2028

Table 9.2 Pharma Contract Manufacturing Market Opportunities and Threats: CMO Perspective, 2017-2028

Table 9.3 Pharma Contract Manufacturing Market: STEP Analysis, 2017-2028

Table 9.4 Selected Lyophilisation Service Providers

Table 9.5 Lyophilisation vs. Spray Drying: A Comparison

Table 9.6 Selected Orphan Drug Prices, 2014

Table 9.7 Selected Biological Manufacturing Expansion, 2013-2017

Table 9.8 Selected EU-Approved Biosimilars: Manufacturers and Companies, 2016

Table 9.9 Selected CMOs Growing Faster than the Market, 2007-2012

Table 9.10 Regional Market Expansion, 2010-2016

Table 10.1 Pharma Contract Manufacturing Market Strengths and Weaknesses: Client Perspective, 2017-2028

Table 10.2 Pharma Contract Manufacturing Market Opportunities and Threats: Client Perspective, 2017-2028

Table 10.3 Benefits and Risks to Outsourcing Pharma Manufacturing

Table 10.4 ICH Guidelines: Key Facts and Adoption, 2000-2014

Table 12.1 Pharma Contract Manufacturing Market: Revenue ($bn), CAGR (%), and Market Share (%) by Sector, 2017, 2022 and 2028

Table 12.2 Pharma Contract Manufacturing Market: Revenue ($bn), CAGR (%), and Market Share (%) by Region, 2017, 2022 and 2028


List of Figures

Figure 1.1 Global Pharmaceutical Contract Manufacturing Market Segmentation Overview, 2017

Figure 2.1 Selected Services Offered by CMOs

Figure 2.2 Major Trends Affecting Pharma Contract Manufacturing Revenue Growth, 2017-2028

Figure 3.1 Pharmaceutical Contract Manufacturing Market Revenue ($bn), 2012-2016

Figure 3.3 Pharma Contract Manufacturing: Market Share (%) by Sector, 2017

Figure 3.4 Pharmaceutical Contract Manufacturing Market: Overall Market Forecast, Revenue ($bn), 2017-2028

Figure 3.5 Pharma Contract Manufacturing Market: Shares (%), 2022

Figure 3.6 Pharma Contract Manufacturing Market: Shares (%), 2028

Figure 3.7 Pharma Contract Manufacturing Market: Drivers, 2017-2028

Figure 3.8 Pharma Contract Manufacturing Market: Restraints, 2017-2028

Figure 3.9 Other Services Submarket Forecast, Revenue ($bn), 2017-2028

Figure 4.1 Contract API Manufacturing Submarket Revenue ($bn), 2012-2016

Figure 4.2 Contract API Manufacturing Submarket: Segment Shares (%) by Sector, 2017

Figure 4.3 Contract API Manufacturing Submarket Forecast, Revenue ($bn), 2017-2028

Figure 4.4 Contract API Manufacturing Submarket: Segment Shares (%), 2022

Figure 4.5 Contract API Manufacturing Submarket: Segment Shares (%), 2028

Figure 4.6 Contract Generic API Manufacturing Submarket Forecast, Revenue ($bn), 2017-2028

Figure 4.7 Contract HPAPI Manufacturing Submarket Forecast, Revenue ($bn), 2017-2028

Figure 5.1 Contract FDF Manufacturing Submarket Revenue ($bn), 2012-2016

Figure 5.2 Contract FDF Manufacturing Submarket: Segment Shares (%) by Sector, 2017

Figure 5.3 Contract FDF Manufacturing Submarket Forecast, Revenue ($bn), 2017-2028

Figure 5.4 Contract FDF Manufacturing Submarket: Segment Shares (%), 2022

Figure 5.5 Contract FDF Manufacturing Submarket: Segment Shares (%), 2028

Figure 5.6 Contract Solid Dosage Manufacturing Submarket Forecast ($bn), 2017-2028

Figure 5.7 Contract Injectable Dosage Manufacturing Submarket Forecast, Revenue ($bn), 2017-2028

Figure 6.1 Pharma Contract Manufacturing Market: Share (%) by Region, 2017

Figure 6.2 Pharmaceutical Contract Manufacturing Market: Share (%) by Region, 2022

Figure 6.3 Pharmaceutical Contract Manufacturing Market: Share (%) by Region, 2028

Figure 6.4 US Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2017-2028

Figure 6.4 Canada Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2017-2028

Figure 6.5 EU5 Pharma Contract Manufacturing Market: Share (%) by Country, 2017

Figure 6.6 EU5 Pharma Contract Manufacturing Market: Share (%) by Country, 2022

Figure 6.7 EU5 Pharma Contract Manufacturing Market: Share (%) by Country, 2028

Figure 6.8 EU5 Pharma Contract Manufacturing Market, Revenue ($bn), 2017-2028

Figure 6.9 German Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2017-2028

Figure 6.10 French Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2017-2028

Figure 6.11 Italian Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2017-2028

Figure 6.12 Spanish Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2017-2028

Figure 6.13 UK Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2017-2028

Figure 6.14 Japanese Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2017-2028

Figure 7.1 Pharma Contract Manufacturing Market: Emerging Market Share (%) by Top Country, 2017

Figure 7.2 Pharma Contract Manufacturing Market: Emerging Market Share (%) by Top Country, 2022

Figure 7.3 Pharma Contract Manufacturing Market: Emerging Market Share (%) by Top Country, 2028

Figure 7.4 Pharma Contract Manufacturing Market: Emerging Market Share (%) by Top Country, 2017, 2022 and 2028

Figure 7.5 Chinese Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2017-2028

Figure 7.6 Indian Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2017-2028

Figure 7.7 Brazilian Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2017-2028

Figure 7.8 Russian Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2017-2028

Figure 7.9 South Korean Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2017-2028

Figure 7.9 Turkey Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2017-2028

Figure 7.10 Mexico Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2017-2028

Figure 8.1 Catalent: Revenue ($bn), 2012-2017

Figure 8.2 Lonza: Revenue (CHF bn), 2012-2017

Figure 8.3 Teva: Revenue ($bn), 2012-2017

Figure 8.4 Boehringer Ingelheim BioXcellence: Revenue ($bn), 2012-2017

Figure 10.1 Overview of Approved ICH Manufacturing Guidelines

Figure 12.1 Pharma Contract Manufacturing Market: Revenue ($bn) by Sector, 2017, 2022 and 2028

Figure 12.2 Pharma Contract Manufacturing Market: Revenue ($bn) by Region, 2017, 2022 and 2028

★調査レポート[医薬品製造受託の世界市場] (コード:VGN808045)販売に関する免責事項を必ずご確認ください。
★調査レポート[医薬品製造受託の世界市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆